CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Bachem AG


Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, the company provides pharmaceutical and biotechnology companies worldwide with products for research, clinical development, and commercial applications, as well as a comprehensive range of services. These include clinical development for new chemical entities (NCEs), commercial GMP manufacturing of peptide and oligonucleotide APIs, custom peptide synthesis for research, amino acid derivatives and building blocks, cosmetic peptides, peptides for diagnostics and medical devices, and a catalog of thousands of research products. With a focus on end-to-end integration, these offerings are supported by project management, quality and regulatory expertise, analytical services, supply services, and vertical integration.
Bachem operates internationally, with headquarters in Switzerland and locations across Europe and the US. The company’s four GMP-certified sites in Switzerland and the United States provide a reliable global supply, with scales ranging from milligrams to multi-tonne commercial volumes.
As a leading partner in TIDES, Bachem combines deep scientific knowledge and technical expertise with a strong commitment to continuous innovation and sustainability. These capabilities support customers bring their products to market with confidence.

Key Services:


CMC Development
Development, GMP production, and regulatory support for peptide and oligonucleotide active pharmaceutical ingredients (APIs)
Commercial APIs
Production of synthetic peptide and oligonucleotide APIs for exclusive NCEs and generic APIs at commercial scale
Research & Specialties
Catalog peptides: Biologically active peptides for research purposes
Custom peptide synthesis: Support to bring your project from research scale to bulk GMP APIs
Diagnostics: Production of peptides for in vitro diagnostics (IVD) at our ISO 13485-certified site in St. Helens
Cosmetics: Supply of cosmetic peptides
Amino acid derivatives: Synthesis and supply of starting materials for peptide manufacturing
 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026